Financial Ratios

GENOMIC VALLEY BIOTECH LTD.

NSE : NABSE : 539206ISIN CODE : INE574D01010Industry : AgricultureHouse : Private
BSE34.92-1.48 (-4.07 %)
PREV CLOSE ( ) 36.40
OPEN PRICE ( ) 36.00
BID PRICE (QTY) 34.97 (483)
OFFER PRICE (QTY) 36.00 (1451)
VOLUME 255
TODAY'S LOW / HIGH ( )34.60 36.00
52 WK LOW / HIGH ( ) 20.6550.14
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)2.12-0.03-1.830.940.76
   CEPS(Rs)2.150.25-1.211.521.40
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)11.559.4214.6916.5215.59
   Tax Rate(%)0.09-466.35-11.41-39.010.94
Margin Ratios
   Core EBITDA Margin(%)32.38-534.82-65.5765.4042.24
   EBIT Margin(%)23.9458.73-155.0945.9724.08
   Pre Tax Margin(%)23.83-2.34-241.1624.3023.83
   PAT Margin (%)23.81-13.24-268.6733.7823.60
   Cash Profit Margin (%)24.10106.31-177.7454.8843.27
Performance Ratios
   ROA(%)15.78-0.16-7.193.783.36
   ROE(%)20.24-0.25-11.735.835.01
   ROCE(%)20.350.93-5.146.104.12
   Asset Turnover(x)0.660.010.030.110.14
   Sales/Fixed Asset(x)1.780.020.040.170.22
   Working Capital/Sales(x)1.620.08-0.29-2.334.31
Efficiency Ratios
   Fixed Capital/Sales(x)0.5664.9627.915.744.58
   Receivable days297.290.00146.9834.7415.14
   Inventory Days0.000.000.0052.3228.15
   Payable days70.373716.00231.43-183.0344.49
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)1.1143.2522.065.314.53
   EV/Core EBITDA(x)3.26-10.40-34.387.9210.35
   EV/EBIT(x)4.6273.64-14.2211.5518.80
   EV/CE(x)0.680.800.600.570.62
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)3758.23-66.09-75.42-14.0665.70
   Core EBITDA Growth(%)414.94-119.75-123.5231.75279.91
   EBIT Growth(%)1472.77112.84-182.9364.09301.97
   PAT Growth(%)7040.4798.33-295.4823.01582.00
   EPS Growth(%)7040.5098.33-295.4823.01582.00
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.340.290.31
   Current Ratio(x)2.895.310.190.534.14
   Quick Ratio(x)2.895.310.190.362.51
   Interest Cover(x)225.300.96-1.802.1296.99
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.